Amarin Corporation plc
Save
–
Market cap
–
Current P/E
588.24x
Forward P/E
About
Health care
Sector
Drug Manufacturers - General
Industry
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally to wholesalers and specialty pharmacy providers.
Similar securities
Based on sector and market capitalization
Report issue